companydata.dkcompanydata.dk

VACCINIUM HOLDING ApS: Financial statements 2024

CVR: 26474639

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

VACCINIUM HOLDING ApS (CVR 26474639) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -101,999 and a net result of DKK -827,704 compared with DKK 1,170,737 the year before. Equity in the 2024 report amounted to DKK 26,565,195. The solvency ratio was 79%.

Gross Profit
DKK -101,999
Profit/Loss
DKK -827,704
Equity
DKK 26,565,195
Total Assets
DKK 33,639,091

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--102K-828K26.6M-
2023--92K1.2M30.5M-
2022--170K2.4M49.6M-
2021--191K1.6M168.1M-
2020--480K2.7M112.4M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

VACCINIUM HOLDING ApS: The 2023 annual report is outJul 10, 2024

VACCINIUM HOLDING ApS has published its annual report for 2023. Gross profit came to DKK -92,198, and the net result was DKK 1,170,737.

About VACCINIUM HOLDING ApS

VACCINIUM HOLDING ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2001. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named KARL KRISTIAN JENSEN ApS. The management consists of Karl Kristian Bergman Jensen. The company is owned by Karl Kristian Bergman Jensen, Bergman Jensen Family Foundation and Louvie Holding S.A.. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -144,218 and a net result of DKK 42,902 compared with DKK -827,704 the year before. Equity in the 2025 report amounted to DKK 36,464,157.

Source: annual report 2025, Danish Business Authority